Repurposing the CRISPR-Cas9 system for targeted DNA methylation

Nucleic Acids Research

Volumn 44, Issue 12, 2016, Pages 5615-5628

  Vojta, Aleksandar ^a   Dobrinic, Paula ^a   Tadic, Vanja ^a   Bockor, Luka ^a   Korac, Petra ^a   Julg, Boris ^b   Klasic, Marija ^a   Zoldos, Vlatka ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; HYBRID PROTEIN; BACH2 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA (CYTOSINE 5) METHYLTRANSFERASE; GLYCOPROTEIN GP 130; GUIDE RNA; IL6ST PROTEIN, HUMAN;

ARTICLE; BACH2 GENE; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; DNA METHYLATION; DNA SEQUENCE; EMBRYO; EPIGENETICS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IL6ST GENE; LIMIT OF QUANTITATION; PRIORITY JOURNAL; PROMOTER REGION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CRISPR-CAS SYSTEMS; CYTOKINE RECEPTOR GP130; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; PROMOTER REGIONS, GENETIC; RNA, GUIDE;

EID: 84979034770     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw159     Document Type: Article

References (44)

1. Doyle, E.L., Stoddard, B.L., Voytas, D.F., Bogdanove, A.J. (2013) TAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteins. Trends Cell Biol., 23, 390-398.
2. Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., Zhang, F. (2013) Genome engineering using the CRISPR-Cas9 system. Nat. Protoc., 8, 2281-2308.
3. Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S., Gregory, P.D. (2010) Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet., 11, 636-646.
4. Carlson, D.F., Tan, W., Lillico, S.G., Stverakova, D., Proudfoot, C., Christian, M., Voytas, D.F., Long, C.R., Whitelaw, C.B., Fahrenkrug, S.C. (2012) Efficient TALEN-mediated gene knockout in livestock. Proc. Natl. Acad. Sci. U.S.A., 109, 17382-17387.
5. Dahlem, T.J., Hoshijima, K., Jurynec, M.J., Gunther, D., Starker, C.G., Locke, A.S., Weis, A.M., Voytas, D.F., Grunwald, D.J. (2012) Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet., 8, e1002861.
6. Falahi, F., Huisman, C., Kazemier, H.G., van der Vlies, P., Kok, K., Hospers, G.A., Rots, M.G. (2013) Towards sustained silencing of HER2/neu in cancer by epigenetic editing. Mol. Cancer Res., 11, 1029-1039.
7. Mendenhall, E.M., Williamson, K.E., Reyon, D., Zou, J.Y., Ram, O., Joung, J.K., Bernstein, B.E. (2013) Locus-specific editing of histone modifications at endogenous enhancers. Nat. Biotechnol., 31, 1133-1136.
8. Hilton, I.B., D'Ippolito, A.M., Vockley, C.M., Thakore, P.I., Crawford, G.E., Reddy, T.E., Gersbach, C.A. (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol., 33, 510-517.
9. Nunna, S., Reinhardt, R., Ragozin, S., Jeltsch, A. (2014) Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cells. PloS One, 9, e87703.
10. Rivenbark, A.G., Stolzenburg, S., Beltran, A.S., Yuan, X., Rots, M.G., Strahl, B.D., Blancafort, P. (2012) Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics, 7, 350-360.
11. Bernstein, D.L., Le Lay, J.E., Ruano, E.G., Kaestner, K.H. (2015) TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. J. Clin. Invest., 125, 1998-2006.
12. Chen, H., Kazemier, H.G., de Groote, M.L., Ruiters, M.H., Xu, G.L., Rots, M.G. (2014) Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res., 42, 1563-1574.
13. Maeder, M.L., Angstman, J.F., Richardson, M.E., Linder, S.J., Cascio, V.M., Tsai, S.Q., Ho, Q.H., Sander, J.D., Reyon, D., Bernstein, B.E. et al. (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat. Biotechnol., 31, 1137-1142.
14. Konermann, S., Brigham, M.D., Trevino, A.E., Hsu, P.D., Heidenreich, M., Cong, L., Platt, R.J., Scott, D.A., Church, G.M., Zhang, F. (2013) Optical control of mammalian endogenous transcription and epigenetic states. Nature, 500, 472-476.
15. Perez-Pinera, P., Kocak, D.D., Vockley, C.M., Adler, A.F., Kabadi, A.M., Polstein, L.R., Thakore, P.I., Glass, K.A., Ousterout, D.G., Leong, K.W. et al. (2013) RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods, 10, 973-976.
16. Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P., Lim, W.A. (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 152, 1173-1183.
17. Barres, R., Yan, J., Egan, B., Treebak, J.T., Rasmussen, M., Fritz, T., Caidahl, K., Krook, A., O'Gorman, D.J., Zierath, J.R. (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab., 15, 405-411.
18. Tsaprouni, L.G., Yang, T.P., Bell, J., Dick, K.J., Kanoni, S., Nisbet, J., Vinuela, A., Grundberg, E., Nelson, C.P., Meduri, E. et al. (2014) Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenetics, 9, 1382-1396.
19. Heerboth, S., Lapinska, K., Snyder, N., Leary, M., Rollinson, S., Sarkar, S. (2014) Use of epigenetic drugs in disease: an overview. Genet. Epigenet., 6, 9-19.
20. Rius, M., Lyko, F. (2012) Epigenetic cancer therapy: rationales, targets and drugs. Oncogene, 31, 4257-4265.
21. Ding, Q., Lee, Y.K., Schaefer, E.A., Peters, D.T., Veres, A., Kim, K., Kuperwasser, N., Motola, D.L., Meissner, T.B., Hendriks, W.T. et al. (2013) A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell, 12, 238-251.
22. Strauss, A., Lahaye, T. (2013) Zinc fingers, TAL effectors, or Cas9-based DNA binding proteins: what's best for targeting desired genome loci Mol. Plant, 6, 1384-1387.
23. Li, F., Papworth, M., Minczuk, M., Rohde, C., Zhang, Y., Ragozin, S., Jeltsch, A. (2007) Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes. Nucleic Acids Res., 35, 100-112.
24. Valton, J., Dupuy, A., Daboussi, F., Thomas, S., Marechal, A., Macmaster, R., Melliand, K., Juillerat, A., Duchateau, P. (2012) Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J. Biol. Chem., 287, 38427-38432.
25. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A. et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819-823.
26. Kungulovski, G., Nunna, S., Thomas, M., Zanger, U.M., Reinhardt, R., Jeltsch, A. (2015) Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained. Epigenetics Chromatin, 8, 12.
27. Oka, M., Rodic, N., Graddy, J., Chang, L.J., Terada, N. (2006) CpG sites preferentially methylated by Dnmt3a in vivo. J. Biol. Chem., 281, 9901-9908.
28. Chen, Z.X., Mann, J.R., Hsieh, C.L., Riggs, A.D., Chedin, F. (2005) Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J. Cell. Biochem., 95, 902-917.
29. Jia, D., Jurkowska, R.Z., Zhang, X., Jeltsch, A., Cheng, X. (2007) Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature, 449, 248-251.
30. Siddique, A.N., Nunna, S., Rajavelu, A., Zhang, Y., Jurkowska, R.Z., Reinhardt, R., Rots, M.G., Ragozin, S., Jurkowski, T.P., Jeltsch, A. (2013) Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J. Mol. Biol., 425, 479-491.
31. Lauc, G., Pezer, M., Rudan, I., Campbell, H. (2015) Mechanisms of disease: The human N-glycome. Biochim. Biophys. Acta, doi:10.1016/j.bbagen.2015.10.016.
32. Lauc, G., Vojta, A., Zoldos, V. (2014) Epigenetic regulation of glycosylation is the quantum mechanics of biology. Biochim. Biophys. Acta, 1840, 65-70.
33. Lauc, G., Huffman, J.E., Pucic, M., Zgaga, L., Adamczyk, B., Muzinic, A., Novokmet, M., Polasek, O., Gornik, O., Kristic, J. et al. (2013) Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet., 9, e1003225.
34. Trbojevic Akmacic, I., Ventham, N.T., Theodoratou, E., Vuckovic, F., Kennedy, N.A., Kristic, J., Nimmo, E.R., Kalla, R., Drummond, H., Stambuk, J. et al. (2015) Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm. Bowel Dis., 21, 1237-1247.
35. O'Brien, A., Bailey, T.L. (2014) GT-Scan: identifying unique genomic targets. Bioinformatics, 30, 2673-2675.
36. Sanjana, N.E., Shalem, O., Zhang, F. (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods, 11, 783-784.
37. Zoldos, V., Horvat, T., Novokmet, M., Cuenin, C., Muzinic, A., Pucic, M., Huffman, J.E., Gornik, O., Polasek, O., Campbell, H. et al. (2012) Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome. Epigenetics, 7, 164-172.
38. Schmittgen, T.D., Livak, K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
39. van Dongen, J.J., Langerak, A.W., Bruggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., Delabesse, E., Davi, F., Schuuring, E., Garcia-Sanz, R. et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 17, 2257-2317.
40. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
41. Schneider, C.A., Rasband, W.S., Eliceiri, K.W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods, 9, 671-675.
42. Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F., Nureki, O. (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 156, 935-949.
43. Van Emburgh, B.O., Robertson, K.D. (2011) Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants. Nucleic Acids Res., 39, 4984-5002.
44. Yang, A.S., Estecio, M.R., Doshi, K., Kondo, Y., Tajara, E.H., Issa, J.P. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32, e38.